Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Sweeney

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Urology|November 7, 2006
The case for systemic therapy alone for prostate cancerChristopher Sweeney
The Lancet. Oncology|January 12, 2013
Prostate cancer therapy: going forwards by going backwardsChristopher Sweeney
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Lessons learned from development of docetaxelRobert Matthew Strother, Christopher Sweeney
The New England Journal of Medicine|January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate CancerJorge A Garcia, Christopher Sweeney,
Pharmaceutical Patent Analyst|November 7, 2014
Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectivesDaniel Altman, Christopher Sweeney, Takuya Yasui
European Urology|May 5, 2009
Testosterone therapy in castrate-resistant prostate cancer: a possible new approachRobert A Gardiner, Christopher Sweeney, Wayne D Tilley
Oncogene|May 29, 2002
Selenomethionine induction of DNA repair response in human fibroblastsYoung R Seo, Christopher Sweeney, Martin L Smith
European Urology|August 28, 2020
When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging ModalitiesNora Sundahl, Silke Gillessen, Christopher Sweeney, et al.
Cancer|June 28, 2023
Top advances of the year: Genitourinary cancerFrancesca Jackson-Spence, Matthew Young, Christopher Sweeney, et al.
European Urology Focus|July 21, 2017
Optimal Treatment Sequence for Metastatic Castration-resistant Prostate CancerDavid Lorente, Karim Fizazi, Christopher Sweeney, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Urology|November 7, 2006
The case for systemic therapy alone for prostate cancerChristopher Sweeney
The Lancet. Oncology|January 12, 2013
Prostate cancer therapy: going forwards by going backwardsChristopher Sweeney
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Lessons learned from development of docetaxelRobert Matthew Strother, Christopher Sweeney
The New England Journal of Medicine|January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate CancerJorge A Garcia, Christopher Sweeney,
Pharmaceutical Patent Analyst|November 7, 2014
Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectivesDaniel Altman, Christopher Sweeney, Takuya Yasui
European Urology|May 5, 2009
Testosterone therapy in castrate-resistant prostate cancer: a possible new approachRobert A Gardiner, Christopher Sweeney, Wayne D Tilley
Oncogene|May 29, 2002
Selenomethionine induction of DNA repair response in human fibroblastsYoung R Seo, Christopher Sweeney, Martin L Smith
European Urology|August 28, 2020
When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging ModalitiesNora Sundahl, Silke Gillessen, Christopher Sweeney, et al.
Cancer|June 28, 2023
Top advances of the year: Genitourinary cancerFrancesca Jackson-Spence, Matthew Young, Christopher Sweeney, et al.
European Urology Focus|July 21, 2017
Optimal Treatment Sequence for Metastatic Castration-resistant Prostate CancerDavid Lorente, Karim Fizazi, Christopher Sweeney, et al.
Pageof 10